Please enable JavaScript to continue using this application.

Compare $RGEN vs $SHC | Chartloom

Compare

$RGEN vs $SHC

Repligen Corp · Sotera Health Co

RGEN

Repligen Corp

SHC

Sotera Health Co

Compare $RGEN vs $SHC

Comparing Repligen Corp and Sotera Health Co

RGENRepligen Corp

SHCSotera Health Co

RGENRepligen Corp

Market cap

$9.81B

P/E (TTM)

237.08x

Forward P/E (NTM)

75.08x

Forward P/S (NTM)

10.82x

Rev growth (TTM)

16.5%

YTD performance

5.8%

52W performance

15.3%

FCF yield

1.1%

SHCSotera Health Co

Market cap

$5.15B

P/E (TTM)

31.83x

Forward P/E (NTM)

17.43x

Forward P/S (NTM)

3.98x

Rev growth (TTM)

8.1%

YTD performance

2.1%

52W performance

12.9%

FCF yield

2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RGEN

SHC

Detailed metrics comparison

RGEN

Repligen Corp

SHC

Sotera Health Co

Market Cap

RGEN$9.81B

SHC$5.15B

Enterprise Value

RGEN$9.76B

SHC$7.03B

Price

RGEN$173.88

SHC$18.06

P/E Ratio

RGEN237.08x

SHC31.83x

P/S Ratio

RGEN12.50x

SHC4.23x

EV/Sales

RGEN12.43x

SHC5.78x

EV/EBITDA

RGEN64.73x

SHC13.41x

P/B Ratio

RGEN4.86x

SHC7.81x

P/FCF Ratio

RGEN89.09x

SHC45.70x

EV/FCF

RGEN88.59x

SHC62.36x

PEG Ratio

RGEN11.27x

SHC3.19x

Forward P/E (NTM)

RGEN75.08x

SHC17.43x

Forward P/S (NTM)

RGEN10.82x

SHC3.98x

Revenue (TTM)

RGEN$785M

SHC$1.22B

Revenue Growth (YoY)

RGEN16.5%

SHC8.1%

Forward Rev Growth

RGEN17.6%

SHC6.0%

Gross Margin (TTM)

RGEN53.8%

SHC55.0%

Operating Margin (TTM)

RGEN6.5%

SHC32.6%

EBITDA Margin (TTM)

RGEN18.8%

SHC43.1%

Net Margin (TTM)

RGEN5.3%

SHC13.4%

FCF Margin (TTM)

RGEN14.0%

SHC9.3%

Net Income (TTM)

RGEN$42M

SHC$163M

FCF (TTM)

RGEN$110M

SHC$113M

EPS (TTM)

RGEN$0.73

SHC$0.57

ROE (TTM)

RGEN2.0%

SHC26.8%

ROA (TTM)

RGEN1.4%

SHC5.0%

ROIC (TTM)

RGEN1.6%

SHC5.7%

Cash

RGEN$607M

SHC$357M

Debt

RGEN$551M

SHC$2.23B

Net Cash/Debt

RGEN$56M

SHC$-1.88B

Current Ratio (TTM)

RGEN9.05x

SHC2.80x

Quick Ratio (TTM)

RGEN7.30x

SHC2.45x

Debt/Equity (TTM)

RGEN0.26x

SHC3.36x

Debt/Assets (TTM)

RGEN0.0%

SHC0.0%

Interest Coverage (TTM)

RGENN/A

SHCN/A

Net Debt/EBITDA (TTM)

RGEN0.00x

SHC0.00x

Beta

RGEN1.13

SHC1.93

52W Performance

RGEN15.3%

SHC12.9%

YTD Performance

RGEN5.8%

SHC2.1%

% from 52W High

RGEN-12.6%

SHC-9.0%

% from 52W Low

RGEN72.2%

SHC38.0%

Asset Turnover (TTM)

RGEN0.27x

SHC0.37x

FCF Yield (TTM)

RGEN1.1%

SHC2.2%

Earnings Yield (TTM)

RGEN0.4%

SHC3.2%

Dividend Yield (TTM)

RGENN/A

SHCN/A

Rule of 40

RGEN30.5

SHC17.4

EV/GP/RG

RGEN1.46

SHC1.64

Ticker research

View RGEN research View SHC research

Metric	RGEN Repligen Corp	SHC Sotera Health Co
Market & Valuation
Market Cap	$9.81B	$5.15B
Enterprise Value	$9.76B	$7.03B
Price	$173.88	$18.06
P/E Ratio	237.08x	31.83x
P/S Ratio	12.50x	4.23x
EV/Sales	12.43x	5.78x
EV/EBITDA	64.73x	13.41x
P/B Ratio	4.86x	7.81x
P/FCF Ratio	89.09x	45.70x
EV/FCF	88.59x	62.36x
PEG Ratio	11.27x	3.19x
Forward P/E (NTM)	75.08x	17.43x
Forward P/S (NTM)	10.82x	3.98x
Revenue & Growth
Revenue (TTM)	$785M	$1.22B
Revenue Growth (YoY)	16.5%	8.1%
Forward Rev Growth	17.6%	6.0%
Profitability
Gross Margin (TTM)	53.8%	55.0%
Operating Margin (TTM)	6.5%	32.6%
EBITDA Margin (TTM)	18.8%	43.1%
Net Margin (TTM)	5.3%	13.4%
FCF Margin (TTM)	14.0%	9.3%
Net Income (TTM)	$42M	$163M
FCF (TTM)	$110M	$113M
EPS (TTM)	$0.73	$0.57
ROE (TTM)	2.0%	26.8%
ROA (TTM)	1.4%	5.0%
ROIC (TTM)	1.6%	5.7%
Financial Health
Cash	$607M	$357M
Debt	$551M	$2.23B
Net Cash/Debt	$56M	$-1.88B
Current Ratio (TTM)	9.05x	2.80x
Quick Ratio (TTM)	7.30x	2.45x
Debt/Equity (TTM)	0.26x	3.36x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.13	1.93
52W Performance	15.3%	12.9%
YTD Performance	5.8%	2.1%
% from 52W High	-12.6%	-9.0%
% from 52W Low	72.2%	38.0%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.37x
FCF Yield (TTM)	1.1%	2.2%
Earnings Yield (TTM)	0.4%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.5	17.4
EV/GP/RG	1.46	1.64
Ticker research	View RGEN research	View SHC research

Valuation

P/E Ratio

SHC

31.83x

RGEN

237.08x

P/S Ratio

SHC

4.23x

RGEN

12.50x

EV/FCF

SHC

62.36x

RGEN

88.59x

Growth & revenue

Revenue Growth TTM

RGEN

16.5%

SHC

8.1%

Forward Revenue Growth

RGEN

17.6%

SHC

6.0%

Profitability & performance

Gross Margin

SHC

55.0%

RGEN

53.8%

ROE

SHC

26.8%

RGEN

2.0%

FCF Yield %

SHC

2.2%

RGEN

1.1%

52-Week Performance

RGEN

15.3%

SHC

12.9%

Detailed metrics comparison

RGEN

Repligen Corp

SHC

Sotera Health Co

Market Cap

RGEN$9.81B

SHC$5.15B

Enterprise Value

RGEN$9.76B

SHC$7.03B

Price

RGEN$173.88

SHC$18.06

P/E Ratio

RGEN237.08x

SHC31.83x

P/S Ratio

RGEN12.50x

SHC4.23x

EV/Sales

RGEN12.43x

SHC5.78x

EV/EBITDA

RGEN64.73x

SHC13.41x

P/B Ratio

RGEN4.86x

SHC7.81x

P/FCF Ratio

RGEN89.09x

SHC45.70x

EV/FCF

RGEN88.59x

SHC62.36x

PEG Ratio

RGEN11.27x

SHC3.19x

Forward P/E (NTM)

RGEN75.08x

SHC17.43x

Forward P/S (NTM)

RGEN10.82x

SHC3.98x

Revenue (TTM)

RGEN$785M

SHC$1.22B

Revenue Growth (YoY)

RGEN16.5%

SHC8.1%

Forward Rev Growth

RGEN17.6%

SHC6.0%

Gross Margin (TTM)

RGEN53.8%

SHC55.0%

Operating Margin (TTM)

RGEN6.5%

SHC32.6%

EBITDA Margin (TTM)

RGEN18.8%

SHC43.1%

Net Margin (TTM)

RGEN5.3%

SHC13.4%

FCF Margin (TTM)

RGEN14.0%

SHC9.3%

Net Income (TTM)

RGEN$42M

SHC$163M

FCF (TTM)

RGEN$110M

SHC$113M

EPS (TTM)

RGEN$0.73

SHC$0.57

ROE (TTM)

RGEN2.0%

SHC26.8%

ROA (TTM)

RGEN1.4%

SHC5.0%

ROIC (TTM)

RGEN1.6%

SHC5.7%

Cash

RGEN$607M

SHC$357M

Debt

RGEN$551M

SHC$2.23B

Net Cash/Debt

RGEN$56M

SHC$-1.88B

Current Ratio (TTM)

RGEN9.05x

SHC2.80x

Quick Ratio (TTM)

RGEN7.30x

SHC2.45x

Debt/Equity (TTM)

RGEN0.26x

SHC3.36x

Debt/Assets (TTM)

RGEN0.0%

SHC0.0%

Interest Coverage (TTM)

RGENN/A

SHCN/A

Net Debt/EBITDA (TTM)

RGEN0.00x

SHC0.00x

Beta

RGEN1.13

SHC1.93

52W Performance

RGEN15.3%

SHC12.9%

YTD Performance

RGEN5.8%

SHC2.1%

% from 52W High

RGEN-12.6%

SHC-9.0%

% from 52W Low

RGEN72.2%

SHC38.0%

Asset Turnover (TTM)

RGEN0.27x

SHC0.37x

FCF Yield (TTM)

RGEN1.1%

SHC2.2%

Earnings Yield (TTM)

RGEN0.4%

SHC3.2%

Dividend Yield (TTM)

RGENN/A

SHCN/A

Rule of 40

RGEN30.5

SHC17.4

EV/GP/RG

RGEN1.46

SHC1.64

Ticker research

View RGEN research View SHC research

Metric	RGEN Repligen Corp	SHC Sotera Health Co
Market & Valuation
Market Cap	$9.81B	$5.15B
Enterprise Value	$9.76B	$7.03B
Price	$173.88	$18.06
P/E Ratio	237.08x	31.83x
P/S Ratio	12.50x	4.23x
EV/Sales	12.43x	5.78x
EV/EBITDA	64.73x	13.41x
P/B Ratio	4.86x	7.81x
P/FCF Ratio	89.09x	45.70x
EV/FCF	88.59x	62.36x
PEG Ratio	11.27x	3.19x
Forward P/E (NTM)	75.08x	17.43x
Forward P/S (NTM)	10.82x	3.98x
Revenue & Growth
Revenue (TTM)	$785M	$1.22B
Revenue Growth (YoY)	16.5%	8.1%
Forward Rev Growth	17.6%	6.0%
Profitability
Gross Margin (TTM)	53.8%	55.0%
Operating Margin (TTM)	6.5%	32.6%
EBITDA Margin (TTM)	18.8%	43.1%
Net Margin (TTM)	5.3%	13.4%
FCF Margin (TTM)	14.0%	9.3%
Net Income (TTM)	$42M	$163M
FCF (TTM)	$110M	$113M
EPS (TTM)	$0.73	$0.57
ROE (TTM)	2.0%	26.8%
ROA (TTM)	1.4%	5.0%
ROIC (TTM)	1.6%	5.7%
Financial Health
Cash	$607M	$357M
Debt	$551M	$2.23B
Net Cash/Debt	$56M	$-1.88B
Current Ratio (TTM)	9.05x	2.80x
Quick Ratio (TTM)	7.30x	2.45x
Debt/Equity (TTM)	0.26x	3.36x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.13	1.93
52W Performance	15.3%	12.9%
YTD Performance	5.8%	2.1%
% from 52W High	-12.6%	-9.0%
% from 52W Low	72.2%	38.0%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.37x
FCF Yield (TTM)	1.1%	2.2%
Earnings Yield (TTM)	0.4%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	30.5	17.4
EV/GP/RG	1.46	1.64
Ticker research	View RGEN research	View SHC research